OncoSil Medical (ASX:OSL) received Medical Device Regulation certification from the European Union notified body BSI Group, according to a Tuesday filing with the Australian bourse.
The certification includes the lifting of existing post-market restrictions for the OncoSil cancer treatment device, simplifying the initiation of commercial treatments, the filing said.
The certification also offers the company a chance to re-submit its application to the Therapeutic Goods Administration for Australian market approval, according to the filing.
Oncosil shares surged 20% in recent trade Wednesday.
Price (AUD): $0.01, Change: $+0.0010, Percent Change: +20.00%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。